Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report
Ziyu Jiang,1,2,* Xiaoli Chen,2,3,* Zhaoshen Sun,2,4 Xiaowei Shen,2,3 Yaju Huang,2,3 Jingbing Liu1,2 1Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People’s Republic of China...
Main Authors: | Jiang Z, Chen X, Sun Z, Shen X, Huang Y, Liu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/toxic-epidermal-necrolysis-and-stevens---johnson-syndrome-following-si-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Case Report: sintilimab-induced Stevens-Johnson Syndrome in a patient with advanced lung adenocarcinoma
by: Xueqin Li, et al.
Published: (2023-09-01) -
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma
by: Huayu Yang, et al.
Published: (2022-12-01) -
Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review
by: Zhang L, et al.
Published: (2023-02-01) -
Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events
by: Lingfang Tu, et al.
Published: (2021-12-01) -
Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer:
A Case Report and Literature Review
by: Jingjing CAI, et al.
Published: (2023-09-01)